Lothar M. Weissbach

Berlin, BE 10117, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Important Studies Were not Mentioned.

Important Studies Were not Mentioned.

Journal: Deutsches Arzteblatt international

Published: March 27, 2026

Barriers to post-prostatectomy stress incontinence care: knowledge gaps, patient concerns, and urologist communication.

Barriers to post-prostatectomy stress incontinence care: knowledge gaps, patient concerns, and urologist communication.

Journal: World journal of urology

Published: September 01, 2025

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer.

Oncological Safety of MRI-Informed Biopsy Decision-Making in Men With Suspected Prostate Cancer.

Journal: JAMA oncology

Published: December 12, 2024

Urologist communication is a primary factor leading to erectile dysfunction treatment postprostatectomy.

Urologist communication is a primary factor leading to erectile dysfunction treatment postprostatectomy.

Journal: The journal of sexual medicine

Published: March 15, 2024

Fifteen-year results of the ProtecT study-commentary

Fifteen-year results of the ProtecT study-commentary

Journal: Urologie (Heidelberg, Germany)

Published: May 08, 2023

Treatment of intermediate-risk prostate cancer with active surveillance in the routine care-Long-term outcomes of a prospective noninterventional study (HAROW).

Treatment of intermediate-risk prostate cancer with active surveillance in the routine care-Long-term outcomes of a prospective noninterventional study (HAROW).

Journal: Current urology

Published: November 28, 2022

Gender-Sensitive Depression Screening (GSDS) - Further Validation of a New Self-Rating Instrument

Gender-Sensitive Depression Screening (GSDS) - Further Validation of a New Self-Rating Instrument

Journal: Psychiatrische Praxis

Published: December 18, 2021

Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer.

Safety and survival of docetaxel and cabazitaxel in metastatic castration-resistant prostate cancer.

Journal: BJU international

Published: July 09, 2021

Correction to: Patient-Specific Mandibular Reconstruction Plates Increase Accuracy and Long-Term Stability in Immediate Alloplastic Reconstruction of Segmental Mandibular Defects.

Correction to: Patient-Specific Mandibular Reconstruction Plates Increase Accuracy and Long-Term Stability in Immediate Alloplastic Reconstruction of Segmental Mandibular Defects.

Journal: Journal of maxillofacial and oral surgery

Published: April 08, 2021

Active surveillance-much safety, little recruitment : Is it possible to extend the indication for "intermediate-risk" prostate cancer?

Active surveillance-much safety, little recruitment : Is it possible to extend the indication for "intermediate-risk" prostate cancer?

Journal: Der Urologe. Ausg. A

Published: March 25, 2021

Surgical Reintervention Rates after Invasive Treatment for Lower Urinary Tract Symptoms due to Benign Prostatic Syndrome: A Comparative Study of More than 43,000 Patients with Long-Term Followup.

Surgical Reintervention Rates after Invasive Treatment for Lower Urinary Tract Symptoms due to Benign Prostatic Syndrome: A Comparative Study of More than 43,000 Patients with Long-Term Followup.

Journal: The Journal of urology

Published: October 26, 2020

Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study.

Active Surveillance for Incidental (cT1a/b) Prostate Cancer: Long-Term Outcomes of the Prospective Noninterventional HAROW Study.

Journal: Urologia internationalis

Published: August 28, 2020

Showing 1-12 of 67

Last Updated: 09/26/2026